Novel Hits Back With Antitrust Charges In Patent Suit
Novel Laboratories Inc. has lobbed counterclaims alleging violations of federal antitrust law at Cima Labs Inc. and Azur Pharma Ltd. in an infringement suit over two patents related to a dosage...To view the full article, register now.
Already a subscriber? Click here to view full article